- Home
- / Vizgen
Vizgen
Total Funding
$51 M
Vizgen Summary
Company Summary
- Overview
- Vizgen is a biotech company developing solutions in single-cell transcriptomics. The company patents the MERFISH (multiplexed error-robust fluorescence in situ hybridization) platform. MERFISH detects and corrects errors found during clinical cell research.
- Type
- Private
- Status
- Active
- Founded
- 2019
- HQ
- Cambridge, MA, US | view all locations
- Website
- https://www.vizgen.com/
- Cybersecurity rating
Table of Contents
Key People
LocationsView all
1 location detected
Cambridge, MA HQ
United States
61 Moulton St